|
|
|
Patients should try to come to consult us personally, for
those that cannot do that, please send or fax to the professional group your recent symptoms, examination, analysis, early diagnose and case history (including patient's address, telephone number, height, weight), after discussion and diagnosis by the professional group, the treatment plan will be informed to the patient and he/she should receive treatment by postage. One can consult the professional group anytime during the treatment.
Tel: +380937434009
+380636018551
Fax:+80971147553
Email:yizi_06@yahoo.com.cn |
|
Miss Wang +380937434009 |
Miss Wang +380636018551 |
Email:yizi_06@yahoo.com.cn |
Address:Bei Xi Liu Lu Zhan Dian Zi Bo Shan Dong China |
Remittance/Payment |
|
|
Gufang Chinese medicine complicated diseases research center is located at Shan Dong Province Zi Bo City, ZhangDian Bei Xi Liu Road; Zi Bo is situated between LuZhong mountain area and LuBei champagne, located at a unique location, its south joins with TaiShan, its north is near by Yellow River, its west is connected with Spring City JiNan, its east is near by beach cities-QingDao, YanTai and WeiHai; it is one of ShanDong Province's five main tourist spots and it is one of the eight tourism city.
>>>more |
|
Dr. Wang Yong, character Shurun, of Han Nationality, is born to the Chinese medicine aristocratic family, he has inherited the essence of traditional Chinese medicine, he uses ancient secret remedies as the base and he complies, matches the results with the special characteristics of modern chronic diseases, high possibility contracted diseases, complicated diseases associated with drugs resistance, .
>>>more |
|
|
|
|
|
| Congress Starts Hearings on FDA's Control of Tobacco |
|
| 2007-10-4 1:03:11 Viewed: [ Font:Large Medium Small] [ Close] |
|
|
Wednesday's hearings on Capitol Hill on whether the U.S. Food and Drug Administration should regulate tobacco have relit a long-smoldering debate.
Those on both sides of the issue remain divided on whether the bill will impact tobacco use, blamed for killing some 436,000 Americans a year, or almost one in every five deaths.
Already, FDA Chairman Dr. Andrew von Eschenbach is on record as saying he does not want his agency to oversee tobacco.
"We could find ourselves in the conundrum of having made a decision about nicotine, only to have made the public health radically worse. And that is not the position FDA is in; we approve products that enhance health, not destroy it," von Eschenbach told the Associated Press in March.
"What I don't want to see happen is that we are in a position where we are determining that a cigarette is safe," he said.
Despite those views, 200 sponsors have lined up to support legislation pending in the House, including Rep. John Dingell, (D-Mich.), chairman of the House Energy & Commerce Committee's Subcommittee on Health, which is hosting this week's hearing.
The bill also has the support of 55 senators and more than 500 public advocacy groups, according to Mathew L. Myers, president of the nonprofit Campaign for Tobacco Free-Kids.
"The hearings are the next step for a bill that is gaining momentum and bipartisan support," said Myers.
One of the bill's more surprising backers: Philip Morris USA, the nation's largest tobacco producer, which controls about half of the U.S. cigarette market, including Marlboro, the nation's bestselling brand.
The company has said it supports legislation as a way of meeting the goal of FDA regulation that was called for in a recent U.S. Institute of Medicine (IOM) report.
"These bills provide the framework for comprehensive FDA regulation of tobacco products and provide important policy solutions to many of the complex issues involving tobacco products," Howard Willard, Philip Morris USA's executive vice president of corporate responsibility, said in a prepared statement. "FDA regulation, as introduced in Congress, would be the most effective way to address the Institute of Medicine's concerns."
Philip Morris's support is the prime reason longtime antismoking crusader Stanton A. Glantz -- the director of the Center for Tobacco Control Research and Education at the University of California, San Francisco -- said he is not supporting the new bill.
"I remain skeptical of the bill, because it's basically going to benefit Philip Morris," Glantz said. "I think that the FDA should have control over tobacco, but not on terms that Philip Morris wrote. I think that the people who are supporting this bill will live to regret it."
Other tobacco companies have lined up against the bill.
John W. Singleton Jr., director of communications at Reynolds American, Inc., whose brands include Camel cigarettes, said that the bill would protect Phillip Morris's market share, in part, by limiting advertising.
"If you make it more difficult to communicate with smokers, and you have half the market, it results in the market share getting locked in," Singleton said. "If you get locked in at 50 percent [like Philip Morris], that's pretty good. The bill gives Phillip Morris a competitive advantage."
Singleton is also concerned about how the FDA would actually regulate tobacco products and the chemicals they contain should the bill become law. "These details aren't clear, and they would need to be worked out," he said.
Identical bills in the House of Representatives and the Senate would grant the FDA the same authority over tobacco that it has over drugs, medical devices and many foods. The bill would allow the agency, which has come under fire in recent years for its monitoring of the drug industry, to regulate the levels of tar, nicotine and other harmful ingredients in cigarettes and smoke. That smoke contains some 4,000 chemicals, more than 40 of which are known to cause cancer.
The bills would also strengthen bans against tobacco advertising and bar tobacco manufacturers from making false claims or use terms such as "light" and "low tar" to describe products. They would also ban cigarette sales to minors and strengthen package warning labels.
The Senate version of the bill would also require that cigarette packs carry graphic warnings illustrating the health risks of smoking.
However, the bills would not require FDA approval of tobacco products already on the market -- only new products would need FDA approval before they could be sold to consumers. In addition, the FDA would have no authority to increase the legal age for buying cigarettes or restrict where cigarettes might be sold.
Still, the hearings themselves are good news, said M. Cass Wheeler, CEO of the American Heart Association.
"We cannot continue to allow the tobacco industry to oversee its own products. That makes as much sense as the three little pigs giving the big bad wolf the keys to their homes," Wheeler said in a statement released Wednesday. "With more than 400 Americans dying each day from cardiovascular diseases caused by smoking, we cannot waste another minute in giving the Food and Drug Administration the authority to regulate the tobacco industry."
|
|
|
